IT|EN
DIABETOLOGY AND ITS COMPLICATIONS · NUTRITION

Low-Glycemic Flour Blend

The study developed and validated a low-glycemic-index (LGI) flour blend (kamut, wholemeal flour and glucomannan) for the preparation of a Neapolitan pizza suitable for patients with type 1 diabetes, balancing palatability, digestibility and glycemic control.

CompletedStatus
12 monthsDuration
Jan 2018Start
Diabetology and its complications · NutritionAreas

The project

The project concerned the development of an LGI dough for Neapolitan pizza, as an alternative to traditional "00" flour and wholemeal flour. The blend was formulated by combining Kamut flour (derived from Khorasan wheat, with a glycemic index of 45 compared with 85 for 00 flour), wholemeal soft-wheat flour and glucomannan (a viscous fibre extracted from the tuber Amorphophallus konjac). The dough was mantained in a temperature- and humidity-controlled environment, baked in an electric oven at 359–380°C for 60–90 seconds, and tested in different proportions by four professional master pizza-makers with the support of a nutritionist, five diabetologists, a nurse and fifty volunteers with type 1 diabetes.

Results

The primary objective was to identify the optimal ratio among the three components to obtain an LGI pizza with good palatability, dough workability and absence of gastrointestinal discomfort. The secondary objective was to assess the metabolic impact of the final product in 50 patients with type 1 diabetes on insulin-pump therapy, comparing postprandial glycemic response at 2, 4 and 12 hours with traditional and wholemeal pizza, while also evaluating subjective satisfaction and the need for insulin-bolus corrections. The optimal blend identified consisted of 70 g of Kamut flour, 30 g of wholemeal flour and 10 g of glucomannan per 120 g dough ball, with 100% agreement among the master pizza-makers. In patients with T1DM, the LGI pizza produced significantly lower postprandial glycemic values than the traditional pizza (148 vs 165 mg/dl at 2h; 145 vs 196 mg/dl at 4h; p<0.05) and normalised next-morning glycemia (137 vs 199 mg/dl; p<0.01). It required reduced insulin supplements (1.8 vs 3.5 IU on average) and was rated as favorably as traditional pizza (80% vs 85%), with comparable digestibility and no adverse gastrointestinal effects.
The flour blend was the subject of a patent application.

Related publications

Scientific evidence

2026
Diabetology and its complications

The Therapeutic Potential Of Incretin-Based Therapies And The Emerging Role Of Metabolic Modulation In The Management Of Obstructive Sleep Apnea: A Mechanistic And Clinical Review

Sandro Gentile, Ersilia Satta, Giuseppina Guarino, Carmine Romano, Felice Strollo

World Journal of Pharmaceutical Science and Research
2026
Diabetology and its complications

Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review

Diana Isaacs, Davida Kruger, Susan Cornell, Sanjay Kalra, Sandro Gentile

Diabetes Therapy
2026
Diabetology and its complications

Consensus Recommendations on Lipohypertrophy: Insights From an International Panel of Experts

Lixin Guo a, David C. Klonoff b, Saud N. Al Sifri c, Yong Mong Bee d, Luis Eduardo Calliari e, Liming Chen…

Diabetes Research and Clinical Practice
2026
Diabetology and its complications

Enhancing Insulin Therapy Adherence Through Technology: Which Needles Do People with Diabetes Prefer?

Sandro Gentile, Raffaella Fiorentino, Maddalena Lettieri, Giuseppina Guarino, Giampiero Marino, Elisabetta Tommasi, Vera Frison, Ersilia Satta, Maria Chiarello, Giuseppe Caccavale, Emilia Masuccio…

MDPI
2025
Diabetology and its complications Review

A Neglected Complication of Insulin Therapy Due to Errors in Injection Technique: Skin Lipohypertrophies: A Narrative Review

Guarino G, Satta E, Gentile S

2025
Diabetology and its complications Review

Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations

Kerr D, Klonoff DC, et al.